.png){kind=icon}
Return
Simplifying complex antibody engineering using machine learning
.png){kind=icon}
OA
AI
DOI：10.1016/j.cels.2023.04.009.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Machine learning is transforming antibody engineering by enabling the generation of drug-like monoclonal antibodies with unprecedented efficiency. Unsupervised algorithms trained on massive and diverse protein sequence datasets facilitate the prediction of panels of antibody variants with native-like intrinsic properties (e.g., high stability), greatly reducing the amount of subsequent experimentation needed to identify specific candidates that also possess desired extrinsic properties (e.g., high affinity). Additionally, supervised algorithms, which are trained on deep sequencing datasets obtained after enrichment of in vitro antibody libraries for one or more specific extrinsic properties, enable the prediction of antibody variants with desired combinations of extrinsic properties without the need for additional screening. Here we review recent advances using both machine learning approaches and how they are impacting the field of antibody engineering as well as key outstanding challenges and opportunities for these paradigm-changing methods.
Keywords:
THERAPEUTIC ANTIBODIES
STABILITY
PREDICTION
SELECTION
Journal
IF:
7.7
Papers:
1.4K
Citations:
1.1W
Organization
Cited Papers
Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods.png)
MABS
OAAI
MABSIF7.3
OAAIShareSaveFast, accurate antibody structure prediction from deep learning on massive set of natural antibodiesNATURE COMMUNICATIONSOAAI
NATURE COMMUNICATIONSIF15.7
OAAIShareSaveShareSaveTherapeutic Monoclonal Antibodies to Complex Membrane Protein Targets: Antigen Generation and Antibody Discovery StrategiesBIODRUGS
BIODRUGSIF6.9
PREAI
ShareSaveShareSave
View more